Premature Therapeutic Antimicrobial Treatments Can Compromise the Diagnosis of Late Periprosthetic Joint Infection

[1]  J. Parvizi,et al.  Definition of periprosthetic joint infection. , 2014, The Journal of arthroplasty.

[2]  J. Parvizi,et al.  Culture-negative periprosthetic joint infection. , 2014, The Journal of bone and joint surgery. American volume.

[3]  J. Parvizi,et al.  Periprosthetic joint infection diagnosis: a complete understanding of white blood cell count and differential. , 2012, The Journal of arthroplasty.

[4]  J. Parvizi,et al.  New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society , 2011, Clinical orthopaedics and related research.

[5]  M. Keith,et al.  American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. , 2011, The Journal of bone and joint surgery. American volume.

[6]  J. Parvizi,et al.  Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. , 2010, The Journal of bone and joint surgery. American volume.

[7]  A. Hanssen,et al.  Prior Use of Antimicrobial Therapy is a Risk Factor for Culture-negative Prosthetic Joint Infection , 2010, Clinical orthopaedics and related research.

[8]  Á. Soriano,et al.  Blood Culture Flasks for Culturing Synovial Fluid in Prosthetic Joint Infections , 2010, Clinical orthopaedics and related research.

[9]  R. Barrack,et al.  Prophylactic Antibiotics Do Not Affect Cultures in the Treatment of an Infected TKA: A Prospective Trial , 2010, Clinical orthopaedics and related research.

[10]  Javad Parvizi,et al.  Diagnosis of Infected Total Knee: Findings of a Multicenter Database , 2008, Clinical orthopaedics and related research.

[11]  I. Sia,et al.  Culture-negative prosthetic joint infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Greenleaf,et al.  Sonication of removed hip and knee prostheses for diagnosis of infection. , 2007, The New England journal of medicine.

[13]  R. Barrack,et al.  Perioperative Antibiotics Should Not Be Withheld in Proven Cases of Periprosthetic Infection , 2007, Clinical orthopaedics and related research.

[14]  R. Barrack,et al.  Periprosthetic infection: what are the diagnostic challenges? , 2006, The Journal of bone and joint surgery. American volume.

[15]  Robin Patel,et al.  The diagnosis of prosthetic joint infection: current techniques and emerging technologies. , 2005, Clinical orthopaedics and related research.

[16]  Robin Patel,et al.  Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. , 2004, The American journal of medicine.

[17]  O. Karaeminoğullari,et al.  C-Reactive Protein Values and Erythrocyte Sedimentation Rates after Total Hip and Total Knee Arthroplasty , 2001, The Journal of international medical research.

[18]  N. Athanasou,et al.  Histological and microbiological findings in non-infected and infected revision arthroplasty tissues , 2000, Archives of Orthopaedic and Trauma Surgery.

[19]  J. Deeks,et al.  Prospective Evaluation of Criteria for Microbiological Diagnosis of Prosthetic-Joint Infection at Revision Arthroplasty , 1998, Journal of Clinical Microbiology.

[20]  A. Yuo,et al.  Erythromycin Inhibition of Lipopolysaccharide-Stimulated Tumor Necrosis Factor Alpha Production by Human Monocytes in Vitro , 1992, The Annals of otology, rhinology & laryngology. Supplement.

[21]  S. Larsson,et al.  C-reactive protein (CRP) levels after elective orthopedic surgery. , 1992, Clinical orthopaedics and related research.

[22]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[23]  M. Gougerot-Pocidalo,et al.  Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide‐stimulated human monocytes to produce IL‐1, IL‐6 and tumour necrosis factor‐alpha , 1991, Clinical and experimental immunology.

[24]  M. Gougerot-Pocidalo,et al.  Effects of quinolones on interleukin 1 production in vitro by human monocytes. , 1987, Immunopharmacology.

[25]  Cummings Cw.  Ann Otol Rhinol Laryngol [Suppl]. , 1978 .

[26]  J. Robotham,et al.  The acute-phase response. , 1995, New horizons.

[27]  M. Gougerot-Pocidalo,et al.  Effects of quinolones on tumor necrosis factor production by human monocytes. , 1990, International journal of immunopharmacology.

[28]  Y. Mizushima,et al.  Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. , 1989, Drugs under experimental and clinical research.